Advertisement
Screener

Enovis Corp (ENOV) Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value

2.1 / 5 stars · 44/106 Roast Me

Enovis Corp Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value

Enovis Corp (ENOV) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value of $4.20 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.

Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue · last filed 2026-02-26

  • Enovis Corp share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2025 was $4.20M, a 4100.00% increase from fiscal 2024.
  • Enovis Corp share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2024 was $100.00K, a 75.00% decline from fiscal 2023.
  • Enovis Corp share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2023 was $400.00K, a 73.33% decline from fiscal 2022.
  • Enovis Corp share-based compensation arrangement by share-based payment award, options, exercises in period, intrinsic value for fiscal 2022 was $1.50M, a 92.99% decline from fiscal 2021.
Period endShare-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 12 monthShare-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value 12 month as first filed
2025-12-31$4.20M
10-K · filed 2026-02-26
2024-12-31$100.00K
10-K · filed 2026-02-26
2023-12-31$400.00K
10-K · filed 2026-02-26
2022-12-31$1.50M
10-K · filed 2025-02-26
2021-12-31$21.40M
10-K · filed 2024-02-22
2020-12-31$1.10M
10-K · filed 2023-03-01
2019-12-31$2.00M
10-K · filed 2022-02-22
$11.20M
10-K · filed 2020-02-24
2018-12-31$1.40M
10-K · filed 2021-02-18
$10.20M
10-K · filed 2019-02-21
2017-12-31$12.30M
10-K · filed 2020-02-24
2016-12-31$6.50M
10-K · filed 2019-02-21
2015-12-31$21.80M
10-K · filed 2018-02-16
2014-12-31$13.30M
10-K · filed 2017-02-14
2013-12-31$9.20M
10-K · filed 2016-02-16
2012-12-31$9.90M
10-K · filed 2015-02-17
2011-12-31$3.80M
10-K · filed 2014-02-12
2010-12-31$1.20M
10-K · filed 2013-02-19

Similar stocks

Stock NameCountryMarket CapPE Ratio
Cadre Holdings, Inc. (CDRE)United States$1.123B33.88
Anteris Technologies Global Corp. (AVR)United States$0.746B
Sanara MedTech Inc. (SMTI)United States$0.323B-6.81
ESTABLISHMENT LABS HOLDINGS INC. (ESTA)$1.954B-65.76
Inogen Inc (INGN)United States$0.139B-7.00
Conexeu Sciences Inc. (CNXU)United States$0.111B
NutriBand Inc. (NTRB)United States$0.109B
LAKELAND INDUSTRIES INC (LAKE)United States$0.104B-4.21
Safe Pro Group Inc. (SPAI)United States$0.090B
MYOMO, INC. (MYO)United States$0.065B-2.85